895
Views
35
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATIONS

A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder

, , , , &
Pages 96-112 | Received 21 Jul 2011, Accepted 21 Dec 2011, Published online: 12 Mar 2012

References

  • American Diabetes Association. 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43–48.
  • American Diabetes Association. 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62–69.
  • Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676.
  • Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. for the BOLDER Study Group. 2005. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162:1351–1360.
  • Daban C, Colom F, Sanchez-Moreno J, García-Amador M, Vieta E. 2006. Clinical correlates of first-episode polarity in bipolar disorder. Compr Psychiatry 47:433–437.
  • Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. 2006. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 67:215–221.
  • Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ. 1997. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 73:47–56.
  • Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. 2004. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217–222.
  • Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, et al. 2004. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432–441.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
  • Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, et al.; Aripiprazole Study Group. 2007. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 68:1480–1491.
  • McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, et al.; for the EMBOLDEN II (Trial D1447C00134) Investigators. 2010. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 71:163–174.
  • Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389.
  • Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. 2006. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 163:217–224.
  • Posner K, Oquendo MA, Gould M, Stanley B, Davies M. 2007. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164:1035–1043.
  • Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. 2003. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64:680–690.
  • Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. 2007. No health without mental health. Lancet 370:859–877.
  • Simpson GN, Angus JWS. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212(Suppl 44):11–19.
  • Suppes T, Vieta E, Liu S, Brecher M, Paulsson B, Trial 127 Investigators. 2009. Maintenance treatment in bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127). Am J Psychiatry 166:476–488.
  • Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, et al; for the BOLDER II Study Group. 2006. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (The BOLDER II Study). J Clin Psychopharmacol 26:600–609.
  • Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, et al. 2006. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247–256.
  • Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. 2008. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109: 251–263.
  • Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B, Trial 144 Study Investigators. 2011. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized study). J Clin Psychiatry 72:1452–1464.
  • Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, et al.; for the EMBOLDEN I (Trial 001) Investigators. 2010. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71:150–162.
  • Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.